In November 2023, the United States Food and Drug Administration (FDA) approved enzalutamide, with or without concurrent leuprolide therapy, for non-metastatic hormone-sensitive prostate cancer (M0 ...

Active surveillance in men with less aggressive prostate cancer is inconsistently used despite clinical guidelines. Renumeration generally favors treatment over conservative management and may ...

To assess the safety and efficacy of using microwave ablation (MWA) to treat solitary kidney (SK) patients with T1a renal cell carcinoma (RCC). Retrospective analysis of a prospectively maintained ...

Purpose: Bladder cancer is one of the most common malignancies worldwide with over 614,000 new cases and 220,000 deaths annually. Five percent of newly diagnosed patients have metastatic disease.

(UroToday.com) As part of the American Urological Association 2020 Virtual Annual Meeting’s AUA guidelines update, Steven Kaplan, MD, from Mount Sinai Medical Center provided updates to the benign ...

Sam Chang hosts Eugene Pietzak to discuss treatment options for BCG-unresponsive bladder cancer and the challenges of evaluating their comparative effectiveness. Dr. Pietzak emphasizes that while ...

Radionuclide therapy has shown promise in the treatment of metastatic castration resistant prostate cancer (mCRPC). Radium-223, an alpha-emitting radioisotope, was the first radiopharmaceutical to ...

Up to 40% of patients with Muscle-invasive bladder cancer (MIBC) are ineligible for cisplatin-based neoadjuvant therapy or radical surgery due to comorbidities. Carriere et al. investigated the ...

Studies have shown that the human microbiome influences the response to systemic immunotherapy. However, only scarce data exist on the impact of the urinary microbiome on the response rates of bladder ...

Outcomes with Novel Combinations in Non-Clear Cell RCC: ORACLE Study - Deepak Kilari ...

Background: Quality assurance in data collection is essential as data quality directly impacts the accuracy and reliability of outcomes. In the context of early detection of prostate cancer, improving ...